4D pharma plc announced that it will receive $30 million in credit facility on July 30, 2021. The company will make monthly interest-only payments through to September 1, 2023, or, subject to the achievement of development milestones, September 1, 2024. The transaction will include participation from new investor Oxford Finance LLC.

On the same date, the company received $12.5 million in its first tranche. The company also issued a warrant, exercisable in five years, which entitles the holder to subscribe for 212,568 new ordinary shares in the company at $1.18 per share. The company will receive remaining $7.5 million and $10 million in tranches dependent on the achievement of certain milestones.